JPRN-C000000036已完成3 期
Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809) - Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 450 人开始时间: 2005年8月4日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 69years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)uncontrolable diabetes mellitus (2)severe complication (infection, heart failure, renal failure, liver failure, etc) (3)anamnesis of heart disease (4)acute or chronic hepatitis, liver chirrosis and portal hypertension (5)synchronous or metachronous malignancy (6)sever plumonary dysfunction (7)CNS invasion (8)HIV positive (9)HBs-Ag positive (10)HCV-Ab positive
研究者
相似试验
已完成
3 期
A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)extensive-disease small cell lung cancerJPRN-UMIN000000720Japan Clinical Oncology Group(JCOG)282
已完成
3 期
Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)Patients with Metatatic Breast CancerJPRN-C000000179Japan Clinical Oncology Group(JCOG)450
已完成
3 期
Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)Stage III colorectal cancerJPRN-C000000193Japan Clinical Oncology Group(JCOG)1,100
已完成
3 期
Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.adult T-cell leukemia / lymphomaJPRN-C000000066Japan Clinical Oncology Group(JCOG)130
已完成
2 期
A Randomized PhaseII/III Study of Concurrent Chemoradiotherapy with Low Dose Cisplatin plus 5-FU versus Concurrent Chemoraiotherapy with Standard Dose Cisplatin plus 5-FU for Locally Advanced Unresetable Esophageal Cancer in the Thorax.(JCOG0303)ocally advanced unresectable esophageal cancer in the thoraxJPRN-UMIN000000861Japan Clinical Oncology Group(JCOG)364